Name | VZV0A4I38W |
---|---|
Synonyms |
CISAPRIDE MONOHYDRATE
UNII:VZV0A4I38W Benzamide, 4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxy-, hydrate (1:1) 4-Amino-5-chloro-N-{(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide hydrate (1:1) VZV0A4I38W |
Description | Cisapride monohydrate is an orally and potent 5-HT4 receptor agonist and hERG inhibitor. Cisapride monohydrate is an prokinetic agent which facilitates or restores motility throughout the length of the gastrointestinal tract. Cisapride monohydrate stimulates gastrointestinal motor activity through an indirect mechanism involving the release of acetylcholine mediated by postganglionic nerve endings in the myenteric plexus of the gut[1][2]. |
---|---|
Related Catalog | |
Target |
5-HT4 Receptor:0.14 μM (EC50) |
References |
[1]. Wiseman, L.R., Faulds, D. Cisapride. Drugs 47, 116–152 (1994). |
Molecular Formula | C23H31ClFN3O5 |
---|---|
Molecular Weight | 483.96 |
Storage condition | -20℃ |
Symbol |
![]() GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H318 |
Precautionary Statements | P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
RIDADR | NONH for all modes of transport |
RTECS | CU9372000 |